Vicki L Sato Denali Therapeutics Inc. (DNLI) insider trading activity
Vicki L Sato is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 107,976 shares of DNLI, which is worth approximately $2.55 Million. The most recent transaction as insider was on Jul 21, 2021, when has been sold 1,666 shares (Common Stock) at a price of $65.09 per share, resulting in proceeds of $108,440. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
108K
6.24%
3M change
12.24%
12M change
Total Value Held
$2.55 Million
VICKI L SATO Transaction History
Also insider at
VLS
Vicki L Sato
Director
New York, NY